Investigational Site Number : 1560013

Lanzhou 730000

0 studies enrolling now · 2 studies all time

What they study most

Hemophilia, Hemophilia A

Studies at this site

• Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A — Running, not enrolling
• Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX — Running, not enrolling